| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |